Back
Krystal Biotech, Inc. 10K Form
Sell
32
KRYS
Krystal Biotech, Inc.
Last Price:
$254.91
Seasonality Move:
7.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KRYS News And Ratings
See the #1 stock for the next 7 days that we like better than KRYS
KRYS Financial Statistics
Sales & Book Value
| Annual Sales: | $389.1M |
|---|---|
| Cash Flow: | $75.4M |
| Price / Cash Flow: | 40.39 |
| Annual Sales: | $41.78 |
| Price / Book: | 6.11 |
Profitability
| EPS (TTM): | 6.84430 |
|---|---|
| Net Income (TTM): | $204.8M |
| Gross Margin: | $360.4M |
| Return on Equity: | 19.22% |
| Return on Assets: | 17.53% |
Krystal Biotech, Inc. Earnings Forecast
Key Krystal Biotech, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for KRYS is 92.61%.
-
The Selling, General & Administrative Expenses for KRYS have been equal to 37.71% of Gross Profit Margin.
-
The Research & Development expenses have been 13.45% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of KRYS is 52.64% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 4 years.
Krystal Biotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KRYS |
| CUSIP: | 501147 |
| Website: | krystalbio.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 9.95 |
| Quick Ratio: | 9.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 37.29 |
|---|---|
| Forward P/E Ratio: | 23.49 |
KRYS Technical Analysis vs Fundamental Analysis
Sell
32
Krystal Biotech, Inc. (KRYS)
is a Sell
Is Krystal Biotech, Inc. a Buy or a Sell?
-
Krystal Biotech, Inc. stock is rated a SellThe current Krystal Biotech, Inc. [KRYS] share price is $255.00. The Score for KRYS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.